Application Notes

Stability optimization of engineered mAbs

Issue link: https://resources.nanotempertech.com/i/1420877

Contents of this Issue

Navigation

Page 4 of 10

©2021 NanoTemper Technologies, Inc. South San Francisco, CA, USA. All Rights Reserved. 5 APPLICATION NOTE Evaluation of mutations on antibodies to determine how they alter multiple stability parameters With the establishment of initial T m , T on , r H , and PDI values for the non-mutated antibodies, it is possible to determine whether the mutant mAbs have significant deviations even with only modest structural alterations. Here we have selected two antibody groups and their mutants, representative from each group of mAbs. In Figure 2A, we see Protein A and its mutants A1-4. Note that overall, the changes the mutations made to profiles was minimal compared to the differences in the initial groups, as seen in Figure 1A and 1B. In Figure 2B, we see similar results for Protein G, where the nanoDSF and turbidity data have broadly similar shapes to the non-mutated molecule; note that the non-mutated molecule's cumulant radius does not indicate a large change in size until a much higher temperature than the mutant molecules. When examining Table 2, it becomes evident that the mutant mAbs did not exhibit significantly increased stability, either thermal or conformational, compared to the non-mutated. However, it also exemplifies the differences that structural changes from single or double mutations can introduce to a molecule. Small changes in the protein sequence can have significant and measurable effects on the biophysical characteristics of a mAb.

Articles in this issue

view archives of Application Notes - Stability optimization of engineered mAbs